| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |